🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don't forget to apply to present at #InnovationDublin25 this year!

Europe just enacted new requirements for device manufacturers to report anticipated product supply disruptions, and U.S. FDA wants the US Congress to follow suit: bit.ly/4jygqwn #MedTech

Everyone can appreciate a two for one deal. And MyStrategist is your one digital home for two of the #medtech industry's most trusted publications. Take a break. Log in to MyStrategist.com to access strategic medtech intelligence: bit.ly/3OnD8su

Orphan devices—specialized #medicaldevices for rare conditions—face #regulatory hurdles under the EU MDR. While new guidance allows some flexibility, challenges remain. How should the EU address orphan device shortages?

Are You Ahead of the Curve in #MedTech? Staying informed isn’t enough—you need strategic intelligence. MedTech Strategist | MedTech's Most Trusted Source delivers insights on market shifts, M&A, regulations, and innovation to help C-suite leaders stay ahead: bit.ly/3SKetBq

Medtech CEOs, investors, and #reimbursement authorities share their views on the current state of #medtech coding, coverage, and payment in the US and the EU, and tell us how #AI and chatbots should be on product companies’ payment radar screens: bit.ly/3CyDgDO

#Medtech has mastered #innovation—but what about the launch? With tougher regs, longer R&D, and complex needs, success is harder than ever. A best-in-class launch can create 2x more value than a mediocre one. Source: L.E.K. Consulting : bit.ly/3WEgJvQ

ICYMI: Life Science Hub CEO Dr. Mark A. Turco discussed his career journey and vision for RI's life sciences sector with @MedTech Strategist. 💻Read the full article: mystrategist.com/medtech-strate…

Each month in Global Spotlight we provide #marketaccess facts from the country spotlighted on the cover of Market Pathways' print issue. The February 2025 cover features Brazilian Health Regulatory Agency (ANVISA) headquarters in Brasília: bit.ly/3QfyUEC

Join Gilde Healthcare's Janke Dittmer, Sofinnova Partners's Aantoine Papiernik, and @EndeavourVision's Alexander Schmitz at #InnovationDublin25 in the panel session "Scaling for Success: Strategies in Later-Stage and Growth Investing" during Day 1 from 12:35pm-1:15pm.

What factor is most critical for a #MedTech startup’s success? Bringing a medtech innovation to market requires navigating complex challenges—from #regulatory strategy to funding and market adoption: bit.ly/4jQIdsf

A panel of #medtech leaders opines on the current state of coding, coverage, and payment; Trump’s FDA retreats from the standards development process; a side-by-side comparison of device supply chain reporting rules in the US and EU; and more: bit.ly/43cQn8B

The future of medtech is taking shape at MedTech Strategist | MedTech's Most Trusted Source #InnovationDB25. From April 29–May 1, join 300+ #medtech leaders, investors, and innovators for exclusive insights, strategic networking, and in-depth industry discussions. Register today: bit.ly/42UeKaX

A Boston start-up takes an innovative approach to local anesthesia that combines safety, duration, and ease of use: bit.ly/3XjRW0u #startups

Explore the barriers and opportunities learn directly from key decision-makers and read stories of companies that are persevering along every pathways of the #medtech market with Market Pathways | MedTech Regulatory & Policy. Learn why you need us for your market access strategy: bit.ly/46Q3lIz

#Robotics pioneer Intuitive continues to be the dominant player with greater than 80% market share, nearly 10,000 da Vinci systems placed, and revenue growth in the mid to high teens, more than 20 years after it introduced the da Vinci robot: bit.ly/4hg6bum

Meet the game-changing presenting companies at #InnovationDublin25. - mailchi.mp/806674eae299/p…

NEW EP. of Market Pathways | MedTech Regulatory & Policy Podcast: Following a robust 2024, the medical device sector continues to thrive in 2025 and remains somewhat insulated from dramatic shifts in #healthcare policies, at least in the short term: bit.ly/42nb0hG

Be the expert in the room. Stay ahead of the curve in #medtech regulatory, reimbursement, and policy with Pathways' Document Depot: bit.ly/4kCLqMi

Medtech has been accelerating innovation in product development with a record 124 new #devices approved by the FDA in 2023. Yet, this speed is not matched in #medtech trials, which can take up to seven years to complete. By Nicole Bongers, Veeva Systems: bit.ly/3FnXkJU